Assessing the Health and Economic Impact of Galantamine Treatment in Patients with Alzheimer???s Disease in the Health Care Systems of Different Countries-Reference-Cited by-同舟云学术

Assessing the Health and Economic Impact of Galantamine Treatment in Patients with Alzheimer???s Disease in the Health Care Systems of Different Countries

Published:2004 Issue:10 Volume:21 Page:677-686
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs & Aging

Author:

Caro Jaime,Salas Maribel,Ward Alexandra,Getsios Denis,Migliaccio-Walle Kristen,Garfield Frances

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Reference39 articles.

1. The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings

2. The Cost of Treatment of Alzheimer??s Disease in The Netherlands

3. Worldwide Prevalence and Incidence of Dementia

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive chemicals in Helianthus tuberosus L may reduce beta-amyloid cytotoxicity as a potential novel treatment for Alzheimer's disease;Studies in Natural Products Chemistry;2023

2. A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer’s disease;Expert Opinion on Pharmacotherapy;2018-07-24

3. Epidemiological and Economic Burden of Alzheimer's Disease: A Systematic Literature Review of Data across Europe and the United States of America;Journal of Alzheimer's Disease;2014-12-23

4. Effectiveness and Cost-Effectiveness of the Pharmacological Treatment of Alzheimer's Disease and Vascular Dementia;Journal of Alzheimer's Disease;2014-09-02

5. The Estimation of Utility Weights in Cost-Utility Analysis for Mental Disorders: A Systematic Review;PharmacoEconomics;2013-11-30